© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Successful management of patients with a drug-eluting coronary stent presenting for elective surgery
Ann Arbor, USA
E-mail: sbengeri@umich.edu
| The first 10% of the full text of this article appears below. |
EditorI read with interest the recent result report of three cases.1 I think the case report was accepted for publication around the time that a meta-analysis from nine randomized trials was presented at the World Cardiology Congress Comparison of sirolimus- and paclitaxel-eluting coronary stents regarding the risk of stent thrombosis. The authors report on a patient1 with a drug-eluting stent (DES) for 18 months who had stent occlusion 7 days after stopping clopidogrel before subacromial decompression.
At present, many surgeons stop all antiplatelet agents for 7 days before surgery.2 The current practice guidelines
Geelong, Australia
* E-mail: steveb@barwonhealth.org.au